Table 3.

Patterns of Failure Outcomes Following TORS for OPSCC.

TORS Study Follow-up (Months) Disease-Free Survival* Control*

Local Regional Distant

Cohen et al.20 24 24/27 (89%) 27/27 (100%) 26/27 (96.3%) 24/27 (89%)
Weinstein et al.53 24 30 (97%) 31 (10%) 30 (97%) 30 (97%)
Park et al.56 24 29 (92%)
Cognetti et al.58 18 1 year: 27 (90%) 29 (97%) 29 (97%) 27 (90%)
Hurtuk et al.59 11.8 52 (96.3%) 53 (98.15%)
Weinstein et al.61 26 1 year:45/47 (96%) 2 years: 26/33 (79%) 46 (98%) 45 (96%) 43 (91.5%)
Genden et al.62 18 23 (78%) 27 (91%) 28 (93%)
White et al.63 24 77/89 (86.5%) 79 (89%) 88 (99%)
Moore et al.68 36 61 (92.4%) 64 (97%) 62 (94%) 65 (98.4%)
*Corresponding to follow-up time, unless otherwise mentioned.

OPSCC, oropharyngeal squamous cell carcinoma; TORS, transoral robotic surgery.

RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2014 April; 5(2): e0010. ISSN: 2076-9172
Published online 2014 April 28. doi: 10.5041/RMMJ.10144